Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Liquid Biopsy for Early Detection of Pancreatic Ductal Adenocarcinoma

  • By

  • Caiming Xu

  • Alessandro Mannucci

  • Haiyong Han

  • Ruben M. Munoz

  • Derek Cridebring

  • Sourat Darabi

  • Yuji Toiyama

  • Yoshinaga Okugawa

  • Gagandeep Singh

  • Mustafa Raoof

  • Joon Oh Park

  • James Lin

  • Gregory Idos

  • Michael J. Demeure

  • Erkut Borazanci

  • Douglas B. Evans

  • Susan Tsai

  • Eunsung Jun

  • Carlos Becerra

  • Scott A. Celinski

  • Laleh Melstrom

  • Vincent Chung

  • Guixin Zhang

  • Dong Shang

  • David L. Bartlett

  • Mitsuro Kanda

  • Song Cheol Kim

  • Valsamo Anagnostou

  • Giulia Martina Cavestro

  • John S. Bolton

  • Ali H. Zaidi

  • Daniel Von Hoff

  • Ajay Goel

  • October 26, 2026

Share

Clinical Scorecard: Correction: Liquid Biopsy for Early Detection of Pancreatic Ductal Adenocarcinoma

At a Glance

CategoryDetail
ConditionPancreatic ductal adenocarcinoma (PDAC), in the context of early detection
Key MechanismsThe correction reports a misspelling of an author’s surname; it provides no information about liquid biopsy mechanisms.
Target PopulationNot specified; the correction does not describe a patient population.
Care SettingPublication correction concerning an article on liquid biopsy for early detection of PDAC.

Key Highlights

  • The correction was published online on 16 September 2026.
  • In the initially published article, Valsamo Anagnostou’s surname was rendered as Anagnastou.
  • The surname has been corrected in both the HTML and PDF versions.
  • The correction concerns the article identified by DOI 10.1038/s41591-026-04625-x.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not reported in the correction.

          No treatment or prescribing information is provided.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma

            • by Caiming Xu, Alessandro Mannucci, Haiyong Han, Ruben M. Munoz, Derek Cridebring, Sourat Darabi, Yuji Toiyama, Yoshinaga Okugawa, Gagandeep Singh, Mustafa Raoof, Joon Oh Park, James Lin, Gregory Idos, Michael J. Demeure, Erkut Borazanci, Douglas B. Evans, Susan Tsai, Eunsung Jun, Carlos Becerra, Scott A. Celinski, Laleh Melstrom, Vincent Chung, Guixin Zhang, Dong Shang, David L. Bartlett, Mitsuro Kanda, Song Cheol Kim, Valsamo Anagnostou, Giulia Martina Cavestro, John S. Bolton, Ali H. Zaidi, Daniel Von Hoff, Ajay Goel

            • October 26, 2026

            Related Content

            A precision T-cell therapy stalls treatment-resistant cancers in clinical trial

            • October 23, 2026

            2026 ASCO Breast Cancer Highlights: SENOMAC

            Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

            • October 15, 2026

            • 1 min
            Influence of virtual dynamic contrast enhanced breast MRI on lesion size, BI-RADS scores and reader confidence